Literature DB >> 9566791

Differential potentiation of anti-mycobacterial activity and reactive nitrogen intermediate-producing ability of murine peritoneal macrophages activated by interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha).

K Sato1, T Akaki, H Tomioka.   

Abstract

The anti-mycobacterial activities of IFN-gamma and TNF-alpha-treated murine peritoneal macrophages were determined. Resident macrophages pretreated with IFN-gamma or TNF-alpha for 2 days were infected with test organisms and subsequently cultured for up to 7 days. First, the early-phase growth of Mycobacterium tuberculosis (days 0-3) was strongly suppressed in IFN-gamma-treated macrophages, and progressive bacterial elimination was subsequently observed. Although TNF-alpha treatment of macrophages did not affect the early phase growth of organisms, bacterial killing was observed in the later phase of cultivation. Second, although IFN-gamma-treated macrophages killed M. avium during the first 3 days of culture, regrowth of the intracellular organisms was subsequently observed. TNF-alpha treatment of macrophages did not influence the mode of intracellular growth of M. avium. Third, IFN-gamma but not TNF-alpha enhanced production of reactive nitrogen intermediates (RNI) by macrophages infected with M. tuberculosis or M. avium, whereas both cytokines increased macrophage release of reactive oxygen intermediates (ROI). The present findings therefore show that IFN-gamma and TNF-alpha potentiated the anti-mycobacterial activity of murine peritoneal macrophages in different fashions. They also suggest that RNI played more important roles than did ROI in the expression of macrophage anti-mycobacterial, particularly anti-M. avium, activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566791      PMCID: PMC1904942          DOI: 10.1046/j.1365-2249.1998.00554.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

Review 1.  Recombinant cytokines for controlling mycobacterial infections.

Authors:  L E Bermudez; G Kaplan
Journal:  Trends Microbiol       Date:  1995-01       Impact factor: 17.079

2.  Strains of Mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro.

Authors:  L O'Brien; J Carmichael; D B Lowrie; P W Andrew
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

Review 3.  Human monocytes/macrophages: NO or no NO?

Authors:  M Denis
Journal:  J Leukoc Biol       Date:  1994-05       Impact factor: 4.962

4.  Growth hormone activation of human monocytes for superoxide production but not tumor necrosis factor production, cell adherence, or action against Mycobacterium tuberculosis.

Authors:  J Warwick-Davies; D B Lowrie; P J Cole
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

5.  Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma.

Authors:  L E Bermudez
Journal:  J Immunol       Date:  1993-03-01       Impact factor: 5.422

6.  Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages.

Authors:  L E Bermudez; M Wu; M Petrofsky; L S Young
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

7.  Selective Mycobacterium avium-induced production of nitric oxide by human monocyte-derived macrophages.

Authors:  C H Dumarey; V Labrousse; N Rastogi; B B Vargaftig; M Bachelet
Journal:  J Leukoc Biol       Date:  1994-07       Impact factor: 4.962

8.  Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis.

Authors:  T Doi; M Ando; T Akaike; M Suga; K Sato; H Maeda
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-gamma and bacterial lipopolysaccharide.

Authors:  Y Vodovotz; N S Kwon; M Pospischil; J Manning; J Paik; C Nathan
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

10.  Selective deactivation of human monocyte functions by TGF-beta.

Authors:  J Warwick-Davies; D B Lowrie; P J Cole
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

View more
  23 in total

1.  Comparative roles of free fatty acids with reactive nitrogen intermediates and reactive oxygen intermediates in expression of the anti-microbial activity of macrophages against Mycobacterium tuberculosis.

Authors:  T Akaki; H Tomioka; T Shimizu; S Dekio; K Sato
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  The CFP-10/ESAT-6 complex of Mycobacterium tuberculosis potentiates the activation of murine macrophages involvement of IFN-gamma signaling.

Authors:  Si Guo; Lang Bao; Zi Fang Qin; Xin Xin Shi
Journal:  Med Microbiol Immunol       Date:  2010-03-16       Impact factor: 3.402

3.  Mycobacterium tuberculosis PPE60 antigen drives Th1/Th17 responses via Toll-like receptor 2-dependent maturation of dendritic cells.

Authors:  Haibo Su; Zhen Zhang; Zijian Liu; Baozhou Peng; Cong Kong; Honghai Wang; Zhi Zhang; Ying Xu
Journal:  J Biol Chem       Date:  2018-05-08       Impact factor: 5.157

4.  The modulating effects of proinflammatory cytokines interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha), and immunoregulating cytokines IL-10 and transforming growth factor-beta (TGF-beta), on anti-microbial activity of murine peritoneal macrophages against Mycobacterium avium-intracellulare complex.

Authors:  C Sano; K Sato; T Shimizu; H Kajitani; H Kawauchi; H Tomioka
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

Review 5.  [Expression of selenoproteins in monocytes and macrophages--implications for the immune system].

Authors:  R Ebert-Dümig; J Seufert; D Schneider; J Köhrle; N Schütze; F Jakob
Journal:  Med Klin (Munich)       Date:  1999-10-15

6.  Cytotoxic T-cell responses to Mycobacterium bovis during experimental infection of cattle with bovine tuberculosis.

Authors:  Margot A Skinner; Natalie Parlane; Allison McCarthy; Bryce M Buddle
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

7.  The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2.

Authors:  Adam J Gehring; Roxana E Rojas; David H Canaday; David L Lakey; Clifford V Harding; W Henry Boom
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  FcgammaRI up-regulation induced by local adenoviral-mediated interferon-gamma production aggravates chondrocyte death during immune complex-mediated arthritis.

Authors:  Karin C Nabbe; Peter L van Lent; Astrid E Holthuysen; Jay K Kolls; Sjef Verbeek; Wim B van den Berg
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

9.  Differential expression of gamma interferon mRNA induced by attenuated and virulent Mycobacterium tuberculosis in guinea pig cells after Mycobacterium bovis BCG vaccination.

Authors:  Amminikutty Jeevan; Teizo Yoshimura; Kyeong Eun Lee; David N McMurray
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  Resistance of macrophages to Mycobacterium avium is induced by alpha2-adrenergic stimulation.

Authors:  Kelly E Weatherby; Bruce S Zwilling; William P Lafuse
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.